These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 1324153)

  • 1. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of parathyroid hormone-related peptide on adenosine 3',5'-monophosphate and ornithine decarboxylase in a human colonic cell line.
    Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
    Endocrinology; 1992 Apr; 130(4):1993-2000. PubMed ID: 1312434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity.
    Gamet L; Cazenave Y; Trocheris V; Denis-Pouxviel C; Murat JC
    Int J Cancer; 1991 Feb; 47(4):633-8. PubMed ID: 1847359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW; Tormay A; Podos SM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vasoactive intestinal peptide on gastric adenocarcinoma.
    Li GH; Qian W; Song GQ; Hou XH
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1328-35. PubMed ID: 17559364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells.
    Kim SW; Beauchamp RD; Townsend CM; Thompson JC
    Surgery; 1991 Aug; 110(2):270-5; discussion 276. PubMed ID: 1713357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
    Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
    Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer growth is inhibited by vasoactive intestinal peptide (VIP) hybrid, a synthetic VIP receptor antagonist.
    Zia H; Hida T; Jakowlew S; Birrer M; Gozes Y; Reubi JC; Fridkin M; Gozes I; Moody TW
    Cancer Res; 1996 Aug; 56(15):3486-9. PubMed ID: 8758916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional VIP receptors in the human mucus-secreting colonic epithelial cell line CL.16E.
    Laburthe M; Augeron C; Rouyer-Fessard C; Roumagnac I; Maoret JJ; Grasset E; Laboisse C
    Am J Physiol; 1989 Mar; 256(3 Pt 1):G443-50. PubMed ID: 2538074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of parathyroid hormone on ornithine decarboxylase activity in human osteosarcoma cells.
    Goto H; Matsui-Yuasa I; Otani S; Morisawa S; Nishizawa Y; Morii H
    Arch Biochem Biophys; 1991 May; 286(2):316-22. PubMed ID: 1654784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
    Broyart JP; Dupont C; Laburthe M; Rosselin G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of ornithine decarboxylase activity and cAMP metabolism to proliferation of normal human bronchial epithelial cells.
    Willey JC; Laveck MA; McClendon IA; Lechner JF
    J Cell Physiol; 1985 Aug; 124(2):207-12. PubMed ID: 2995414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
    Chastre E; Emami S; Rosselin G; Gespach C
    Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathways for the regulation of ornithine decarboxylase in intestinal epithelial cells.
    Ginty DD; Marlowe M; Pekala PH; Seidel ER
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G454-60. PubMed ID: 2107756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone-induced ornithine decarboxylase activity in fetal rat osteoblasts.
    Van Leeuwen JP; Bos MP; Herrmann-Erlee MP
    J Bone Miner Res; 1989 Aug; 4(4):485-92. PubMed ID: 2554685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and forskolin regulate proliferation of the HT29 human colon adenocarcinoma cell line.
    Gamet L; Murat JC; Remaury A; Remesy C; Valet P; Paris H; Denis-Pouxviel C
    J Cell Physiol; 1992 Mar; 150(3):501-9. PubMed ID: 1371513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.